Vendome Acquisition CORP I Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
Meteora Capital, LLC, through its managed funds, has reported beneficial ownership of 1,961,501 shares, representing 9.81% of the Class A common stock of Vendome Acquisition Corp I.
NASDAQ
First Trust Capital Management and associated entities have filed a Schedule 13G/A reporting a 5.46% beneficial ownership stake in Vendome Acquisition Corp I.
NASDAQ
Meteora Capital, LLC and Vik Mittal have reported beneficial ownership of 9.99% of Vendome Acquisition Corp I's Class A common stock as of March 31, 2026.
NASDAQ
Glazer Capital, LLC and Paul J. Glazer have reported beneficial ownership of over 5% of Vendome Acquisition Corporation I's Class A ordinary shares.
NASDAQ
Meteora Capital, LLC and its managing member, Vik Mittal, have disclosed a 9.99% beneficial ownership stake in Vendome Acquisition Corp I's Class A common stock.
NASDAQ
Barclays PLC has filed an amended Schedule 13G, reporting beneficial ownership of 450 common shares, representing 0.00% of Vendome Acquisition Corp-A.
NASDAQ
First Trust Merger Arbitrage Fund and related entities have disclosed beneficial ownership of up to 9.25% of Vendome Acquisition Corp I's Class A Ordinary Shares.
NASDAQ
Meteora Capital, LLC and its Managing Member, Vik Mittal, reported a 9.99% beneficial ownership stake in Vendome Acquisition Corp I's Class A common stock.
NASDAQ
Vendome Acquisition Sponsor I LLC and Vendome Acquisition Holding I LLC have filed an amended Schedule 13G, disclosing a 20% beneficial ownership in Vendome Acquisition Corp I's Class A Ordinary Shares.
NASDAQ
Sculptor Capital and its affiliates have reported zero beneficial ownership in Vendome Acquisition Corp I Class A Ordinary Shares, indicating a full divestment or reduction below the 5% reporting threshold.
NASDAQ
Glazer Capital, LLC and Paul J. Glazer have reported a 6.37% beneficial ownership stake in Vendome Acquisition Corporation I's Class A ordinary shares.
NASDAQ
Barclays PLC has reported a beneficial ownership of 8.42% in Vendome Acquisition Corp-A's common stock as of September 30, 2025.
NASDAQ
Magnetar Financial LLC and its affiliates have reported a 9.25% beneficial ownership stake in Vendome Acquisition Corp I, totaling 1,850,000 Class A ordinary shares.
NASDAQ
Vendome Acquisition Sponsor I LLC and Vendome Acquisition Holding I LLC jointly report a 22.3% beneficial ownership stake in Vendome Acquisition Corp I, primarily through Founder Shares.
NASDAQ
Sculptor Capital LP and its affiliates have disclosed a beneficial ownership of 9% in Vendome Acquisition Corp I's Class A Ordinary Shares, totaling 1,800,000 shares.